Submission Details
| 510(k) Number | K964278 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 28, 1996 |
| Decision Date | November 22, 1996 |
| Days to Decision | 25 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
K964278 is an FDA 510(k) clearance for the WHOLE BLOOD GLUCOSE CONTROL LEVEL 1,2,AND 3/WHOLE BLOOD GLUCOSE LINEARITY CONTROL-LEVEL1,2,3,4,5,AND 6, a Single (specified) Analyte Controls (assayed And Unassayed) (Class I — General Controls, product code JJX), submitted by Clinical Controls, Inc. (Grover Beach, US). The FDA issued a Cleared decision on November 22, 1996, 25 days after receiving the submission on October 28, 1996. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1660.
| 510(k) Number | K964278 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 28, 1996 |
| Decision Date | November 22, 1996 |
| Days to Decision | 25 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
| Product Code | JJX — Single (specified) Analyte Controls (assayed And Unassayed) |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 862.1660 |